These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4623010)

  • 1. Immune deficiency states associated with malignant disease in man.
    Harris J; Bagai RC
    Med Clin North Am; 1972 Mar; 56(2):501-14. PubMed ID: 4623010
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pathogenesis of immunologic deficiency diseases associated with lymphoproliferative disorders].
    Ponzone A; Tarocco RP; Nicola P
    Minerva Pediatr; 1970 Dec; 22(51):2542-60. PubMed ID: 4993895
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current trends in therapy and prophylaxis of immunological disorders in malignant hemoreticulopathies].
    Berceanu S; Gociu M
    Stud Cercet Med Interna; 1969; 10(3):197-208. PubMed ID: 4186583
    [No Abstract]   [Full Text] [Related]  

  • 4. [Significance of the HL-A-antigensystem in tumor research].
    Kuwert E; Bertrams J
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1972; 78(2):204-18. PubMed ID: 4264844
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunological aspects of malignant lymphoproliferative diseases].
    Rivero I; Diumenjo M
    Rev Clin Esp; 1977 Mar; 144(6):403-9. PubMed ID: 140441
    [No Abstract]   [Full Text] [Related]  

  • 6. [The incidence of chronic lymphoid leukemia antigen in other malignant hematologic diseases].
    Do TP; Petrányi G; Hollán Z
    Orv Hetil; 1974 Apr; 115(16):930-1. PubMed ID: 4206891
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum immunoglobulin E levels in patients with neoplastic disease.
    Waldmann TA; Bull JM; Bruce RM; Broder S; Jost MC; Balestra ST; Suer ME
    J Immunol; 1974 Jul; 113(1):379-86. PubMed ID: 4208923
    [No Abstract]   [Full Text] [Related]  

  • 8. Examinations of the bactericidal properties of the serum against gram-positive microbes in patients suffering from leukaemia, malignant lymphoma, myeloma and myelofibrosis.
    Libánský J; Jezková Z
    Experientia; 1964 Mar; 20(3):124-7. PubMed ID: 5322537
    [No Abstract]   [Full Text] [Related]  

  • 9. [Blastic lymphocyte transformation caused by phytohemagglutinin in patients with lymphoproliferative diseases].
    Mantovani G; Petrini MT; Tognella S; Grifoni V
    Boll Soc Ital Biol Sper; 1972 Jul; 48(14):381-5. PubMed ID: 4628299
    [No Abstract]   [Full Text] [Related]  

  • 10. Impaired immunoresponsiveness in tumor patients.
    Harris J; Copeland D
    Ann N Y Acad Sci; 1974; 230():56-85. PubMed ID: 4595955
    [No Abstract]   [Full Text] [Related]  

  • 11. Presence of chronic lymphoid leukaemia associated antigen in other malignant haematological diseases.
    Phan DT; Petrányi GG; Hollán SR
    Vox Sang; 1974 Feb; 26(2):141-6. PubMed ID: 4207851
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of cancer on the immune globulins and immunity.
    Fahey JL
    Proc Natl Cancer Conf; 1964; 5():417-20. PubMed ID: 4159237
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative studies on serum and saliva IgaA-levels in leukemias and paraproteinemias].
    Patakfalvi A; Miszlay Z; Böhm G
    Blut; 1971; 22(2):86-92. PubMed ID: 5000154
    [No Abstract]   [Full Text] [Related]  

  • 14. [The antibody deficiency syndrome].
    Ricci G
    G Mal Infett Parassit; 1966 Dec; 18(12):Suppl:979-88. PubMed ID: 4173181
    [No Abstract]   [Full Text] [Related]  

  • 15. [In-vitro biosynthesis of gamma-globulins in congenital and acquired dysproteinemias].
    Aiuti F; Fontana L
    Minerva Med; 1972 Mar; 63(22):1274-80. PubMed ID: 4623012
    [No Abstract]   [Full Text] [Related]  

  • 16. Lymphocyte surface markers in lymphoproliferative disorders.
    Aiuti F; Lacava V; Fiorilli M; Ciarla MV
    Acta Haematol; 1973; 50(5):275-83. PubMed ID: 4202631
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunofluorescence studies in human leukemia.
    Bates HA; Bankole RO; Swaim WR
    Blood; 1969 Oct; 34(4):431-40. PubMed ID: 4309683
    [No Abstract]   [Full Text] [Related]  

  • 18. Invited discussion: kinetic approach to the study of cell-mediated immunity in Hodgkin's disease.
    Hersh EM
    Natl Cancer Inst Monogr; 1973 May; 36():123-4. PubMed ID: 4744573
    [No Abstract]   [Full Text] [Related]  

  • 19. The investigation of the immunological reactivity of patients with haemoblastosis.
    Libánský J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1965; 84(2):172-89. PubMed ID: 4161254
    [No Abstract]   [Full Text] [Related]  

  • 20. Malignant disease of the lymphoid system in immunological perspective.
    Hansen JA; Good RA
    Hum Pathol; 1974 Sep; 5(5):567-99. PubMed ID: 4137052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.